| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/08/2008 | WO2008052354A1 Method of treating demyelination diseases |
| 05/08/2008 | WO2008052352A1 Substituted quinone indoleamine 2,3-dioxygenase (ido) inhibitors and syntheses and uses therefor |
| 05/08/2008 | WO2008052350A1 Photodynamic therapy for the treatment of hidradenitis suppurativa |
| 05/08/2008 | WO2008052338A1 Analysis of receptor biology using ligand coated beads |
| 05/08/2008 | WO2008052323A1 Liposome encapsulated poly-iclc method to prophylactically treat an avian influenza viral infection |
| 05/08/2008 | WO2008052295A1 Process for the preparation of compounds of at1 receptor antagonists with angiotensin-(1-7), analogues thereof and/or mixtures of these systems, pharmaceutical compositions thereof and use of their derivative products |
| 05/08/2008 | WO2008052288A1 Dithiole compounds as cox inhibitors |
| 05/08/2008 | WO2008052279A1 Organo-arsenoxide compounds and use thereof |
| 05/08/2008 | WO2008052256A1 Prevention and reversal of chemotherapy-induced peripheral neuropathy |
| 05/08/2008 | WO2008052238A1 Treatment of urological cancer |
| 05/08/2008 | WO2008039431A3 Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid |
| 05/08/2008 | WO2008039359A3 Bicyclic pyrimidine kinase inhibitors |
| 05/08/2008 | WO2008039327A3 Method of treatment using fatty acid synthesis inhibitors |
| 05/08/2008 | WO2008036410A3 Methods and compositions for treating amyotrophic lateral sclerosis (als) |
| 05/08/2008 | WO2008036379A3 Serine hydrolase inhibitors |
| 05/08/2008 | WO2008036308A3 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| 05/08/2008 | WO2008035982B1 COMBINATION OF A GLUCOCORTICOID AND A β-CYCLODEXTRIN CONJUGATED VITAMIN A DERIVATE COMPLEX |
| 05/08/2008 | WO2008035365A8 Rna interference mediated inhibition of aurorakinase b and its combinations as anticancer therapy |
| 05/08/2008 | WO2008034895A3 Ansamycin derivatives |
| 05/08/2008 | WO2008034891A3 Novel genes related to glutaminyl cyclase |
| 05/08/2008 | WO2008034863A3 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 05/08/2008 | WO2008034735A3 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| 05/08/2008 | WO2008033300A3 Bis (thiohydrazide amides) formulation |
| 05/08/2008 | WO2008032103A3 Process for the preparation of an (rp)-8-substituted camps |
| 05/08/2008 | WO2008029152A3 Treatment of duchenne muscular dystrophy |
| 05/08/2008 | WO2008028935A3 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 05/08/2008 | WO2008025819A3 Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 05/08/2008 | WO2008024371A3 Multimediator transporter inhibitors for use in treatment of central nervous system disorders |
| 05/08/2008 | WO2008024302A8 Compounds for treating proliferative disorders |
| 05/08/2008 | WO2008024301A8 Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
| 05/08/2008 | WO2008020305A3 Solid dosage forms of bisphosphonic acids |
| 05/08/2008 | WO2008017381A8 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
| 05/08/2008 | WO2008016911A3 Replicating melatonin signaling in a fetus, newborn or suckling infant |
| 05/08/2008 | WO2008016192A3 Fused heterocyclic derivative and use thereof |
| 05/08/2008 | WO2008012635A3 Amine derivatives useful as anticancer agents |
| 05/08/2008 | WO2008011109A3 Substituted pyridone compounds and methods of use |
| 05/08/2008 | WO2008010953A3 Pyridinone diketo acids: inhibitors of hiv replication in combination therapy |
| 05/08/2008 | WO2008009963A3 Pyrimidine derivatives as modulators of parathyroid hormone receptors |
| 05/08/2008 | WO2008009407A3 Sulphonylaminocarbonyl derivatives of bile acid amides for use as immunomodulators |
| 05/08/2008 | WO2008008879A3 Nanoparticulate formulations of modafinil |
| 05/08/2008 | WO2008008718B1 Cyclopentane derivatives as antiglaucoma agents |
| 05/08/2008 | WO2008007153A3 Antiviral compounds |
| 05/08/2008 | WO2008006715A3 Improvements relating to pharmaceutical compositions |
| 05/08/2008 | WO2008005240A3 Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof |
| 05/08/2008 | WO2008004127A3 Method for administering tolperisone |
| 05/08/2008 | WO2008003637A3 Isolation and use of amine salts of mycophenolic acid |
| 05/08/2008 | WO2008002591A3 Methods for treating atherosclerosis |
| 05/08/2008 | WO2008001219A3 Cancer therapy using bcl-xl-specific sina |
| 05/08/2008 | WO2007149797A3 Use of organic compounds |
| 05/08/2008 | WO2007149482A3 Xanthohumol based protein kinase modulation cancer treatment |
| 05/08/2008 | WO2007147889A3 Preparation of telmisartan salts |
| 05/08/2008 | WO2007147480A3 Polymorphic forms and process |
| 05/08/2008 | WO2007146856A3 Substituted gamma lactams as therapeutic agents |
| 05/08/2008 | WO2007146138A3 Thiadiazole compounds and methods of use thereof |
| 05/08/2008 | WO2007143557A3 Compounds and methods for treating mammalian gastrointestinal parasitic infections |
| 05/08/2008 | WO2007142792A3 Potent inhibition of influenza virus by specifically designed short interfering rna |
| 05/08/2008 | WO2007140551A3 Treatment of cnidaria intoxication with vanilloid receptor antagonists |
| 05/08/2008 | WO2007139930A3 Drug combinations with substituted diaryl ureas for the treatment of cancer |
| 05/08/2008 | WO2007139887A3 Methods for treating bone or joint inflammation |
| 05/08/2008 | WO2007138116A3 Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown |
| 05/08/2008 | WO2007137258A3 C-glycolipids with enhanced th-1 profile |
| 05/08/2008 | WO2007135529A3 Azabenzimidazolyl compounds as mglur2 potentiators |
| 05/08/2008 | WO2007129226A3 Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders |
| 05/08/2008 | WO2007120752A3 4, 5-dihydro- [1, 2, 4] triazolo [4, 3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders |
| 05/08/2008 | WO2007118205A3 Compounds, compositions and methods for treating hormone-dependent maladies |
| 05/08/2008 | WO2007117687A3 Implants for the treatment of dopamine associated states |
| 05/08/2008 | WO2007114948A3 Methods and compositions for inhibiting cell death |
| 05/08/2008 | WO2007112288A3 Cardiovascular composition and use the same for the treatment of alzheimers disease |
| 05/08/2008 | WO2007110709A3 Formulations of tipifarnib for intravenous administration |
| 05/08/2008 | WO2007107162A3 Small internally segmented interfering rna |
| 05/08/2008 | WO2007095041A3 Pharmaceutical formulations |
| 05/08/2008 | WO2007095039A3 Pharmaceutical formulations |
| 05/08/2008 | WO2007081583A8 Anti-pneumococcal preparations and methods of use |
| 05/08/2008 | WO2007072216A3 Kit and composition of imidazole with enhanced bioavailability |
| 05/08/2008 | WO2007070643A3 Compositions and methods for treating dermatological conditions |
| 05/08/2008 | WO2007067814A3 Targeting gli proteins in human cancer by small molecules |
| 05/08/2008 | WO2007060038A3 Preparation, comprising iron(iii) complex compounds and redox-active substances |
| 05/08/2008 | WO2007056388A3 Compositions and methods for modulating poly (adp-ribose) polymerase activity |
| 05/08/2008 | WO2007042262A8 Ophthalmic emulsions containing prostaglandins |
| 05/08/2008 | WO2007039749A3 Antibacterial pyrrols |
| 05/08/2008 | WO2007038271A9 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
| 05/08/2008 | WO2007018588A8 Stable pharmaceutical composition comprising linezolid form iv |
| 05/08/2008 | WO2007017176A8 Wound-healing composition |
| 05/08/2008 | WO2006127810A8 Bacterial cellulose-containing formulations and method of producing effective bacterial cellulose-containing formulations |
| 05/08/2008 | WO2005030211A8 Aerosol formulation for inhalation, containing an anticholinergic agent |
| 05/08/2008 | WO2004092191A8 Polymeric oligonucleotide prodrugs |
| 05/08/2008 | WO1999048916A8 Hypoxia-inducible human genes, proteins, and uses thereof |
| 05/08/2008 | US20080109040 Method of treating arrhythmias |
| 05/08/2008 | US20080108840 Useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108819 Novel indole derivatives and their use as medicament |
| 05/08/2008 | US20080108809 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108801 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs |
| 05/08/2008 | US20080108707 treating with honokiol, honokiol-type compound or magnolol, magnolol-type compound; skin disorders, cancer |
| 05/08/2008 | US20080108706 dosage forms contains N1,N14-Diethyl-3(R) 12(R)-dihydroxyhomospermine for TREATMENT OF PANCREATIC CANCER |
| 05/08/2008 | US20080108705 Treatment of diabetes with copper bunding compounds |
| 05/08/2008 | US20080108704 Hydroalcoholic compositions thickened using polymers |
| 05/08/2008 | US20080108703 Methods for Improving Bioavailability of a Renin Inhibitor |